Tens of millions of Americans won’t realize that the country’s lead immunologist, Dr. Anthony Fauci, just delivered outstandingly good news regarding a new COVID-19 vaccine.
And they won’t realize it because they’ve been conditioned – by Democrats – to distrust everything about the pandemic, including new treatments that could (and likely will) save lives, coming from the Trump administration.
The Blaze has additional details:
According to a report from Yahoo! Finance, Fauci, director of the National Institute of Allergy and Infectious Diseases, cautioned that early vaccines are simply aimed at preventing or reducing symptoms of coronavirus infection.
Fauci made the remarks during Monday’s Yahoo! Finance’s All Markets Summit.
“If the vaccine allows you to prevent initial infection, that would be great,” he said in remarks. “[But] the primary endpoint [is] to prevent clinically recognizable disease.”
At the time of this reporting, four biotechnology companies are nearing their end of clinical trials as they furiously work to develop a vaccine for COVID-19 — AstraZeneca, Johnson & Johnson, Moderna, and Pfizer, which is partnered with BioNTech.
“The primary thing you want to do is that if people get infected, prevent them from getting sick, and if you prevent them from getting sick, you will ultimately prevent them from getting seriously ill,” Fauci said.
“If the vaccine also allows you to prevent initial infection, that would be great. [But] what I would settle for, and all of my colleagues would settle for, is the primary endpoint to prevent clinically recognizable disease,” he continued.
So, you might be thinking, ‘only’ 50-60 percent effective. That means nearly half of Americans vaccinated would not be ‘protected,’ per se.
Yes, well, according to the most recent data, last year’s flu vaccine was less effective.
In February, the Centers for Disease Control and Prevention, last year’s flu vaccine was only 45 percent effective.
“According to data from the U.S. Influenza Vaccine Effectiveness Network on 4,112 children and adults with acute respiratory illness during October 23, 2019–January 25, 2020, the overall estimated effectiveness of seasonal influenza vaccine for preventing medically attended, laboratory-confirmed influenza virus infection was 45%,” the CDC’s report says.
According to former AAFP Vaccine Science Fellow John Epling, M.D., M.S.Ed., of Roanoke, Va., that means the vaccine is about as effective as it typically is in a season when it offers a decent match to circulating influenza antigens.
“The meaning of the effectiveness number gets misinterpreted frequently,” he told AAFP News. “While we would all want an even more effective vaccine, it remains the best way we have to prevent flu and its complications.”
And last year was a “relatively severe flu season” because, as of February — as COVID was spreading — the flu was still a ‘thing.’
One other thing: Last year’s flu season affected between 39 million and 56 million people, killing between 24,000-62,000 people.
Now, if we were counting flu deaths like we’re counting COVID deaths, how much higher would last year’s flu death toll would have been?